Screening for Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence, Challenges, and the Role of Imaging—From the AJR Special Series on Screening

AMERICAN JOURNAL OF ROENTGENOLOGY · Published 2026-07-29 · DOI 10.2214/ajr.26.34836

Authors (13)

Shin Mei Chan, Cheng William Hong, Lael Ceriani, Manish Dhyani, Kathryn J. Fowler, Michael S. Middleton, Theodore T. Pierce, Perry J. Pickhardt, Scott B. Reeder, Anthony E. Samir, Adam Searleman, Dorathy Tamayo-Murillo, Claude B. Sirlin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chan, S., Hong, C., Ceriani, L., et al. (2026). Screening for Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence, Challenges, and the Role of Imaging—From the AJR Special Series on Screening. AMERICAN JOURNAL OF ROENTGENOLOGY. https://doi.org/10.2214/ajr.26.34836

Related articles